Related Experiment Video
Updated: Apr 27, 2026

14:58
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
3.8K
CMV-induced pathology: pathway and gene-gene interaction analysis
Michael Melnick1, Krysta A Deluca1, Tina Jaskoll1
1Laboratory for Developmental Genetics, USC, 925 W 34th Street, Los Angeles, CA 90089-0641, USA.
Experimental and Molecular Pathology
|July 2, 2014
Summary
Human cytomegalovirus (hCMV) is linked to salivary gland mucoepidermoid carcinoma (SG-MEC). A mathematical model reveals gene network crosstalk that may limit anti-kinase therapy effectiveness.
Area of Science:
- Oncology
- Virology
- Bioinformatics
Background:
- Mucoepidermoid carcinoma (MEC) is the most common malignant tumor of salivary glands (SGs).
- Human cytomegalovirus (hCMV) has been identified as a key factor in the multifactorial causation of SG-MEC.
- The tumor microenvironment (TME), especially cancer-associated fibroblasts (CAFs), significantly regulates disease progression.
Purpose of the Study:
- To investigate the mechanistic insights into SG-MEC pathogenesis.
- To model the complex gene network interactions within SG-MEC.
- To understand the limitations of targeted anti-kinase therapies.
Main Methods:
- Utilized a three-dimensional in vitro mouse model with mouse CMV (mCMV) to study malignant transformation of SG cells.
- Analyzed aberrant expression of ECM components, growth factors, cytokines, and transcription factors in early CAFs.
- Developed a mathematical "wiring diagram" to model a 32-gene cancer network and its relationships.
Main Results:
- Demonstrated that mCMV can induce malignant transformation of SG cells via similar oncogenic signaling pathways as hCMV.
- Identified critical crosstalk and compensatory pathways within the 32-gene cancer network.
- Exposed the functional architecture of the gene network, highlighting its complexity.
Conclusions:
- hCMV plays a significant role in the development of SG-MEC.
- The intricate network of gene interactions presents challenges for targeted therapies.
- Understanding these network dynamics is crucial for developing effective treatment strategies for SG-MEC.

